Great Point Partners’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Great Point Partners’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-390,000	Closed	-$45M	–	44
2020 Q4	$45M	Sell	390,000 -130,232	-25%	-$14.6M	7.31%	1
2020 Q3	$50.6M	Buy	520,232 +70,232	+16%	+$8.08M	4.56%	9
2020 Q2	$55.2M	Hold	450,000	–	–	4.41%	10
2020 Q1	$39.4M	Buy	450,000 +308,317	+218%	+$32.6M	4.12%	10
2019 Q4	$14.8M	Buy	+141,683	New	+$15.9M	1.29%	20
2018 Q1	–	Sell	-75,000	Closed	-$9.9M	–	52
2017 Q4	$9.9M	Buy	+75,000	New	+$8.81M	1.69%	24

Other funds holding GWPH

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Great Point Partners's GWPH Position: Q1 2021 in Review

Great Point Partners sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2021, closing a stake of 390,000 shares — an estimated $45M sold.

Great Point Partners first reported a position in GWPH in Q4 2017 and held it in 6 quarters. The position peaked at $55.2M in Q2 2020. 297 funds tracked by Wall St. Rank hold GWPH as of Q1 2021.

Great Point Partners reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2021 after selling out during the quarter.
Great Point Partners sold 390,000 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2021, an estimated $45M.
Great Point Partners first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2017 and held it in 6 quarters.
Great Point Partners's GW Pharmaceuticals Plc American Depositary Shares position peaked at $55.2M in Q2 2020.
297 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2021.

Based on Great Point Partners's 13F filing for Q1 2021, filed 17 May 2021.